DrugPatentWatch Database Preview
Details for Patent: 6,099,859
Summary for Patent: 6,099,859
| Title: | Controlled release oral tablet having a unitary core |
| Abstract: | A controlled release antihyperglycemic tablet that does not contain an expanding polymer and comprising a core containing the antihyperglycemic drug, a semipermeable membrane coating the core and at least one passageway in the membrane. |
| Inventor(s): | Cheng; Xiu Xiu (Davie, FL), Chen; Chih-Ming (Davie, FL), Jan; Steve (Coral Springs, FL), Chou; Joseph (Coral Springs, FL) |
| Assignee: | Andrx Pharmaceuticals, Inc. (Fort Lauderdale, FL) |
| Application Number: | 09/045,330 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,099,859 |
|
Patent Claim Types: see list of patent claims | Dosage form; Formulation; Device; |
Drugs Protected by US Patent 6,099,859
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,099,859
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 3101999 | Start Trial | |||
| Australia | 739226 | Start Trial | |||
| Canada | 2324493 | Start Trial | |||
| China | 1158999 | Start Trial | |||
| China | 1308520 | Start Trial | |||
| Germany | 69941115 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
